🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07233694
Starting soon Not applicable

IM İnjection-PAIN-Cold Spray and Stress Ball

NCT07233694 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-11-25
Last updated
2025-11-18

Condition(s) studied

Pain, ProceduralAcute PainInjection Site

Investigational drug(s) / intervention(s)

cold spray gruopstress ball gruop

cold spray gruop: Arm Description: Before skin cleansing; cooling spray will be applied to a 10 cm2 area in the injection area from a distance of 15 cm for 5 seconds and diclofenac sodium injection will be applied within 15 seconds (Çetin and Avşar, 2022; Cevheroğlu and Büyükyılmaz, 2023). • IM injection protocol will be followed.

stress ball gruop: The patients in the group will first be told how to use the ball. After the VG area to be injected is determined, a stress ball will be given to the patient's hand opposite the injection area and they will be asked to squeeze and loosen the ball. They will be told to repeat this until the procedure is completed.

Study summary

Brief Summary:

Intramuscular (IM) injection is a widely used method for drug administration, with over 12 billion applications globally each year. Despite its therapeutic advantages, IM injection often causes pain, which can negatively impact patient comfort and lead to injection fear, non-compliance, and avoidance of healthcare services. Effective pain management during IM injection is an ethical and professional responsibility for nurses. This randomized controlled study aims to compare the effectiveness of cold spray and stress ball squeezing methods against standard practice in reducing IM injection-related pain. The study will be conducted in the emergency department of a university hospital in Turkey between March and June 2025, involving 66 patients prescribed IM diclofenac sodium. Participants will be randomly assigned to one of three groups: cold spray, stress ball, or control. Pain will be assessed using the Visual Analog Scale (VAS) within the first minute after injection.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: Adults aged 18-65 years Receiving intramuscular injection Voluntarily agreed to participate in the study Exclusion Criteria: Skin disease at the injection site Allergy to cold spray Cognitive impairment preventing cooperation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Erzincan Binali Yıldırım University Erzincan Turkey (Türkiye)

More Erzincan Binali Yildirim Universitesi trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07233694 on ClinicalTrials.gov ↗ ← All trials in Turkey